Editorial policy
Sourcing
We use three kinds of source, in this order of preference: peer-reviewed clinical trial results and regulatory documents; official provider pricing pages; and independent certification records such as LegitScript. Where we cite a trial, we name it so you can look it up.
Verification
Every price on this site was read from the provider's own public pages at the date stamped on the page. We do not carry over pricing from other comparison sites, because much of what circulates in this niche is out of date — the widely repeated $99 compounded semaglutide figure from Hims, for example, describes a route that narrowed sharply after March 2026.
What we will not publish
- Efficacy claims beyond what the trial evidence supports
- Invented testimonials, invented authors or invented credentials
- Before-and-after imagery presented as typical results
- Compounded medication presented as equivalent to FDA-approved medication
- Urgency devices such as countdown timers or fake scarcity
Illustrations
All charts and diagrams on this site are generated by us from the same verified pricing data the pages are built from, so an illustration can never drift out of step with the text. Provider marks are our own typographic placeholders, not the companies' logos. We use no stock photography of people, because in a medical context it implies patients and outcomes that do not exist.
Limitations we will state plainly
We are a small independent publisher, not a clinical organisation. We do not conduct original clinical research, we do not test medication, and we do not have a medical review board. Where we describe clinical matters we are summarising published evidence, and we say so. Every provider we rank pays us a commission, which we disclose on every page.
Corrections
If we get something wrong we fix the page and, where the error was material, note what changed. Report errors to hello@tirzeptides.com.